COVID-19 Updates
From the Journals
COVID vaccines lower risk of serious illness in children
“The findings in this report support the recommendation for COVID-19 vaccination for all children aged ≥6 months and highlight the importance of...
News from the FDA/CDC
New CDC advisory once again flags BA.2.86 COVID variant
The variant accounted for nearly 9% of cases during the 2-week period ending Nov. 25, up from 3% during the previous 2 weeks.
Conference Coverage
AI tool perfect in study of inflammatory diseases
A model that combines machine learning with clinical cues could help clinicians easily differentiate MIS-C from typhus, a new study found.
News from the FDA/CDC
CDC says child vaccination exemptions hit all-time high
The overall national vaccination rate remained steady at 93% for children entering kindergarten for the 2022-2023 school year.
From the Journals
Long COVID and mental illness: New guidance
“Long COVID is real, and mental health conditions do not cause long COVID.”
From the Journals
Sensory comeback: New findings show the path to smell and taste recovery after COVID
“... There are still people suffering from it. ... It really has a significant psychological impact.”
News from the FDA/CDC
FDA to health care providers: Double-check COVID vaccine dose for children
“Parents were telling us of cases where pharmacies accidentally gave their children a double dose, while doctors in our group were pointing out...
Letters from Maine
Right under our noses
Study results suggest that perhaps we should be giving more attention to the development of nasal vaccines.
From the Journals
COVID coronary plaque infection confirms CV risk
The findings may not only explain the link between COVID and the increased risk of cardiovascular events but mark a starting point for new...
From the Journals
Vaccination status doesn’t impact infectivity timeline in kids
”Current policies requiring isolation for 5 days after a positive test might be appropriate, as the majority of children were not infectious by...
ID Consult
Preparing for the viral trifecta: RSV, influenza, and COVID-19